Severe Group A and Group B Streptococcus Diseases at a Pediatric ICU: Are they Still Sensitive to the Penicillins?

Kam L Hon1, Tai C Chow1, Tsun S Cheung1

  • 1Faculty of Medicine, The Chinese University of Hong Kong, Central Ave, Hong Kong.

Insights

Severe Group A and B Streptococcus infections in children are rare but deadly, requiring intensive care. Prompt antibiotic treatment and supportive care are crucial for survival in Pediatric Intensive Care Units (PICU).

Area of Science:

  • Pediatric Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Group A Streptococcus (GAS) and Group B Streptococcus (GBS) are significant pediatric pathogens.
  • Severe infections, though uncommon, carry high mortality and morbidity, often needing intensive care.

Purpose of the Study:

  • To review the mortality and morbidity associated with severe GAS and GBS infections in a Pediatric Intensive Care Unit (PICU).

Main Methods:

  • Retrospective analysis of children admitted to a PICU between October 2002 and May 2018.
  • Inclusion criteria: laboratory-proven GAS and GBS isolations.

Main Results:

  • 19 patients (0.7% PICU admissions) identified with GAS (n=11) or GBS (n=8).
  • GBS affected younger infants; cerebrospinal fluid was more often positive in GBS cases.
  • Nearly 40% mortality observed, with high rates of mechanical ventilation and inotropic support.

Conclusions:

  • Severe GAS and GBS infections pose significant risks in the PICU, despite rarity.
  • Penicillin remains effective; prompt recognition and treatment are vital.
  • High PIM2 and Sepsis scores indicate the need for timely intensive care interventions.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
323
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
896
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249